EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Avoidable Mortality Across US States and High-Income Countries

Irene Papanicolas, Maecey Niksch, Jose F Figueroa

JAMA Internal Medicine · 01.05.2025 · 185 (5) · 583

DOI: 10.1001/jamainternmed.2025.0155 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA Internal Medicine, erschienen am 01.05.2025. Verfasst von Irene Papanicolas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island. Hauptthemen laut MEDLINE: Developed Countries, COVID-19, Mortality. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Although there are increasing differences in health policy and population health across US states over the past decade, little is known about how US states compare with other countries on avoidable mortality.

Objective

To compare trends in avoidable mortality across US states and countries in the European Union (EU) and the Organisation for Economic Co-operation and Development (OECD). Design, Setting, and Participants Retrospective, population-based, repeated cross-sectional study comparing changes in avoidable mortality among decedents aged 0 to 74 years in 50 US states (and Washington, DC) and 40 high-income countries between 2009 and 2021. Data analysis was conducted from May to July 2024. Main Outcomes and Measures Avoidable mortality comprising both preventable deaths related to prevention and public health and treatable deaths related to timely and effective health care treatment.

Results

Between 2009 and 2019, total avoidable mortality increased in all US states (median [IQR], 29.0 [20.1 to 44.2] deaths per 100 000 people), while it decreased in most comparator countries (−14.4 [−28.4 to −8.0]). During this period, variation in avoidable mortality widened across US states (2009: median [IQR], 251.1 [228.4 to 280.4]; 2019: 282.8 [249.1 to 329.5]), but narrowed in comparator countries (2009: 201.5 [166.2 to 320.8]; 2019: 187.1 [152.0 to 298.2]). During the COVID-19 pandemic (2019-2021), avoidable mortality increased for all US states (median [IQR], 101.5 [64.7 to 143.1]) and comparator countries (25.8 [9.1 to 117.7]). The states and countries that experienced the greatest increase in avoidable deaths during the COVID-19 period were those with the highest baseline avoidable mortality (Pearson ρ = 0.86; P < .001). Health spending and avoidable mortality have a consistent, negative, and significant association among comparator countries (2019: Pearson ρ = −0.7; P < .001) but no statistically significant association within US states (2019: Pearson ρ = −0.12; P = .41). Conclusions and Relevance This cross-sectional study found that the stark contrast in avoidable mortality trends between all US states compared with EU and OECD countries suggests that broad, systemic factors play a role in worsening US population health. While other countries appear to make gains in health with increases in health care spending, such an association does not exist across US states, raising questions regarding US health spending efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Developed CountriesCOVID-19MortalityHumansUnited StatesCross-Sectional StudiesRetrospective StudiesMiddle AgedAdultChildAgedMaleInfantChild, PreschoolFemaleAdolescentYoung AdultInfant, Newborn

Autor:innen und Institutionen

  • Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island.
  • Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Zitieren

APA

Papanicolas, I., Niksch, M., & Figueroa, J. F. (2025). Avoidable Mortality Across US States and High-Income Countries. JAMA Internal Medicine, 185(5), 583. https://doi.org/10.1001/jamainternmed.2025.0155

Vancouver

Papanicolas I, Niksch M, Figueroa JF. Avoidable Mortality Across US States and High-Income Countries. JAMA Internal Medicine. 2025;185(5):583. doi:10.1001/jamainternmed.2025.0155

BibTeX
@article{Papanicolas2025,
  author = {Papanicolas, Irene and Niksch, Maecey and Figueroa, Jose F},
  title = {Avoidable Mortality Across US States and High-Income Countries},
  journal = {JAMA Internal Medicine},
  year = {2025},
  volume = {185},
  number = {5},
  pages = {583},
  doi = {10.1001/jamainternmed.2025.0155}
}
Kostenlos starten →